Author:
Sorokina I. V.,Zhukova N. A.,Meshkova Yu. V.,Baev D. S.,Tolstikova T. G.,Bakarev M. A.,Lushnikova E. L.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference14 articles.
1. Tyuzikov IA, Kalinchenko SYu. Benign prostatic hyperplasia as a systemic hormone-metabolic disease: time to change paradigm of pathogenesis and drug therapy. Effekt. Farmakoter. Urol. Nefrol. 2016;(4):32-53. Russian.
2. Briganti A, Capitanio U, Suardi N, Gallina A, Salonia A, Bianchi M, Tutolo M, Di GirolamoV, Guazzon G, Rigatti P, Montorsi F. Benign prostatic hyperplasia and its aetiologies. Eur. Urol. Suppl. 2009;(8):865-871. https://doi.org/10.1016/j.eursup.2009.11.002
3. Ho CK, Habib FK. Estrogen and androgen signaling in the pathogenesis of BPH. Nat. Rev. Urol. 2011;8(1):29-41. https://doi.org/10.1038/nrurol.2010.207
4. La Vignera S, Condorelli RA, Russo GI, Morgia G, Calogero AE. Endocrine control of benign prostatic hyperplasia. Andrology. 2016;4(3):404-411. https://doi.org/10.1111/andr.12186
5. Rastrelli G, Vignozzi L, Corona G, Maggi M. Testosterone and benign prostatic hyperplasia. Sex Med. Rev. 2019;7(2):259-271. https://doi.org/10.1016/j.sxmr.2018.10.006
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献